Terms: = Endocrine gland cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Prognosis
127 results:
1. MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian cancer.
Flores-Colón M; Rivera-Serrano M; Reyes-Burgos VG; Rolón JG; Pérez-Santiago J; Marcos-Martínez MJ; Valiyeva F; Vivas-Mejía PE
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612604
[TBL] [Abstract] [Full Text] [Related]
2. Complexity of the Genetic Background of Oncogenesis in Ovarian cancer-Genetic Instability and Clinical Implications.
Murawski M; Jagodziński A; Bielawska-Pohl A; Klimczak A
Cells; 2024 Feb; 13(4):. PubMed ID: 38391958
[TBL] [Abstract] [Full Text] [Related]
3. SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling.
Sun M; Zhao M; Li R; Zhang Y; Shi X; Ding C; Ma C; Lu J; Yue X
Cell Death Dis; 2024 Jan; 15(1):87. PubMed ID: 38272883
[TBL] [Abstract] [Full Text] [Related]
4. PINK1-pten axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.
Zheng F; Zhong J; Chen K; Shi Y; Wang F; Wang S; Tang S; Yuan X; Shen Z; Tang S; Xia D; Wu Y; Lu W
J Exp Clin Cancer Res; 2023 Nov; 42(1):295. PubMed ID: 37940999
[TBL] [Abstract] [Full Text] [Related]
5. Anaplastic thyroid cancer:Improved understanding of what remains a deadly disease.
Cleere EF; Prunty S; O'Neill JP
Surgeon; 2024 Feb; 22(1):e48-e53. PubMed ID: 37866980
[TBL] [Abstract] [Full Text] [Related]
6. pten deficiency exposes a requirement for an ARF GTPase module for integrin-dependent invasion in ovarian cancer.
Nikolatou K; Sandilands E; Román-Fernández A; Cumming EM; Freckmann E; Lilla S; Buetow L; McGarry L; Neilson M; Shaw R; Strachan D; Miller C; Huang DT; McNeish IA; Norman JC; Zanivan S; Bryant DM
EMBO J; 2023 Sep; 42(18):e113987. PubMed ID: 37577760
[TBL] [Abstract] [Full Text] [Related]
7. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
Kitazawa S; Chiyoda T; Nakamura K; Sakai K; Yoshihama T; Nishio H; Kobayashi Y; Iwata T; Banno K; Yamagami W; Nishihara H; Aoki D
Int J Clin Oncol; 2023 Nov; 28(11):1554-1562. PubMed ID: 37574505
[TBL] [Abstract] [Full Text] [Related]
8. Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance.
Guo Z; Ashrafizadeh M; Zhang W; Zou R; Sethi G; Zhang X
Cancer Metastasis Rev; 2024 Mar; 43(1):29-53. PubMed ID: 37453022
[TBL] [Abstract] [Full Text] [Related]
9. Clinical and Proteomic-Based Molecular Characterizations of Invasive and Noninvasive Somatotroph PitNETs.
Chen M; Duan L; Sun W; Guo Z; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
Neuroendocrinology; 2023; 113(9):971-986. PubMed ID: 37253344
[TBL] [Abstract] [Full Text] [Related]
10. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
11. circACTR2 attenuates gemcitabine chemoresiatance in pancreatic cancer through pten mediated PI3K/AKT signaling pathway.
Xu C; Ye Q; Ye C; Liu S
Biol Direct; 2023 Mar; 18(1):14. PubMed ID: 36991449
[TBL] [Abstract] [Full Text] [Related]
12. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer.
van Bommel MHD; Pijnenborg JMA; van der Putten LJM; Bulten J; Snijders MPLM; Küsters-Vandevelde HVN; Sweegers S; Vos MC; Ligtenberg MJL; Eijkelenboom A; de Hullu JA; Reijnen C
Int J Gynecol Cancer; 2022 Dec; 32(12):1568-1575. PubMed ID: 36384753
[TBL] [Abstract] [Full Text] [Related]
14. Complete pathological response following chemotherapy and radiotherapy in two cases of advanced anaplastic thyroid carcinoma.
Chevalier B; Karleskind O; Jannin A; Farchi O; Vermaut C; Escande A; Baillet C; Espiard S; Vantyghem MC; Carnaille B; Leteurtre E; Do Cao C
Eur Thyroid J; 2023 Feb; 12(1):. PubMed ID: 36377723
[TBL] [Abstract] [Full Text] [Related]
15. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience.
Xu B; Lubin DJ; Dogan S; Ghossein RA; Viswanathan K
Virchows Arch; 2023 Mar; 482(3):479-491. PubMed ID: 36346459
[TBL] [Abstract] [Full Text] [Related]
16. Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
[TBL] [Abstract] [Full Text] [Related]
17. Gold Nanoparticles Disrupt the IGFBP2/mTOR/pten Axis to Inhibit Ovarian cancer Growth.
Hossen MN; Wang L; Dwivedi SKD; Zhang Y; Rao G; Elechalwar CK; Sheth V; Dey A; Asfa S; Gulla SK; Xu C; Fung KM; Robertson JD; Bieniasz M; Wilhelm S; Bhattacharya R; Mukherjee P
Adv Sci (Weinh); 2022 Nov; 9(31):e2200491. PubMed ID: 36104215
[TBL] [Abstract] [Full Text] [Related]
18. MiR-135b improves proliferation and regulates chemotherapy resistance in ovarian cancer.
Wang J; Zhang R; Zhang B; Zhang L; Jiang W; Liu X; Duan X
J Mol Histol; 2022 Aug; 53(4):699-712. PubMed ID: 35793009
[TBL] [Abstract] [Full Text] [Related]
19. Exosomal MicroRNA as Biomarkers for Diagnosing or Monitoring the Progression of Ovarian Clear Cell Carcinoma: A Pilot Study.
Horie K; Nanashima N; Yokoyama Y; Yoshioka H; Watanabe J
Molecules; 2022 Jun; 27(12):. PubMed ID: 35745075
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological and molecular profile of grade 3 gastroenteropancreatic neuroendocrine neoplasms.
Taboada R; Claro L; Felismino T; de Jesus VH; Barros M; Riechelmann RP
J Neuroendocrinol; 2022 Apr; 34(4):e13099. PubMed ID: 35174558
[TBL] [Abstract] [Full Text] [Related]
[Next]
